Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$542
+$143 QoQ
Shares Held
2
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#835
of 844 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Seneschal Advisors, LLC holds $91,853 across 12 Diagnostics & Research names. NTRA ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
167 | $83,726 | |
| 2 | MYGN |
Myriad Genetics Inc
|
350 | $1,998 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
1 | $1,277 | |
| 4 | WAT |
Waters Corp /De/
|
2 | $750 | |
| 5 | DGX |
Quest Diagnostics Inc
|
3 | $635 | |
| 6 | DHR |
Danaher Corp /De/
|
3 | $571 | |
| 7 | LH |
Labcorp Holdings Inc.
|
2 | $560 | |
| 8 | NTRA |
Natera, Inc.
This page
|
2 | $542 |
All Filings in NTRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $542 | 2 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $399 | 2 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $458 | 2 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $321 | 2 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||